Recent Trends in ADPKD Research
Authors:
- 13 October 2016
- book chapter
- Published by Springer Nature
- Vol. 933, 3-11
Abstract
Autosomal Dominant Polycystic Kidney Disease (ADPKD) is one of the most common inherited disorders. It is the fourth leading cause of renal replacement and renal failure worldwide. Mutations in PKD1 or PKD2 cause ADPKD. Patients with ADPKD show progressive growth of renal cysts filled with cystic fluid, leading to end-stage renal disease (ESRD) and renal failure by their sixth decade of life. Currently, there are no curative treatments for ADPKD. Therefore, patients require dialysis or kidney transplantation. To date, researchers have elucidated many of the mechanisms that cause ADPKD and developed many methods to diagnose the disease. ADPKD is related to growth factors, signaling pathways, cell proliferation, apoptosis, inflammation, the immune system, structural abnormalities, epigenetic mechanisms, microRNAs, and so on. Various therapies have been reported to slow the progression of ADPKD and alleviate its symptoms.Keywords
This publication has 50 references indexed in Scilit:
- Polycystin-1: a master regulator of intersecting cystic pathwaysTrends in Molecular Medicine, 2014
- Scoring a backstage pass: Mechanisms of ciliogenesis and ciliary accessJournal of Cell Biology, 2012
- c-Src inactivation reduces renal epithelial cell-matrix adhesion, proliferation, and cyst formationAmerican Journal of Physiology-Cell Physiology, 2011
- The Raf kinase inhibitor PLX5568 slows cyst proliferation in rat polycystic kidney disease but promotes renal and hepatic fibrosisNephrology Dialysis Transplantation, 2011
- Loss of Primary Cilia Upregulates Renal Hypertrophic Signaling and Promotes CystogenesisJournal of the American Society of Nephrology, 2011
- Autosomal Dominant Polycystic Kidney DiseaseNew England Journal of Medicine, 2010
- Methylation determines fibroblast activation and fibrogenesis in the kidneyNature Medicine, 2010
- Polycystin-1 Regulates Extracellular Signal-Regulated Kinase-Dependent Phosphorylation of Tuberin To Control Cell Size through mTOR and Its Downstream Effectors S6K and 4EBP1Molecular and Cellular Biology, 2009
- Role of matrix metalloproteinases in renal pathophysiologiesAmerican Journal of Physiology-Renal Physiology, 2007
- Transmembrane crosstalk between the extracellular matrix and the cytoskeletonNature Reviews Molecular Cell Biology, 2001